Publications by authors named "Ruiyan Mei"

Article Synopsis
  • Mesenchymal stem cells (MSCs) show great potential as candidates for new drugs due to their immune regulation and ability to target tumors.
  • They are being researched for applications in cancer therapy and treatment of inflammatory and fibrotic diseases.
  • The review discusses various strategies for using MSCs in drug delivery and highlights current limitations and challenges in getting stem cell therapies into clinical use.
View Article and Find Full Text PDF

Exosomes serve as a promising therapeutic nanoplatform. However, the exosomes produced by donor cells are a heterogeneous group, with only a small portion having high therapeutic efficacy. Specific isolation of the subpopulation with high efficacy is important for lowering the dose and minimizing toxicity.

View Article and Find Full Text PDF

Background: Exosomes are recognized as effective platforms for targeted delivery for their high physicochemical stability and biocompatibility. However, most of the exosomes are inevitably and rapidly cleared by mononuclear phagocytic system (MPS) during cancer therapy. How to engineer exosome to enhance the delivery efficiency is being intensively explored.

View Article and Find Full Text PDF

Adipose tissues perform physiological functions such as energy storage and endocrine, whose dysfunction will lead to severe metabolic disorders. Accumulating evidences show that exosomes can meditate communications between different tissues by transporting nucleic acids, proteins and other biological factors. More importantly, exosomes secreted by adipose tissue function as critical contributing factors that elucidate specific mechanisms in metabolic disturbance such as obesity, adipose inflammation and diabetes etc.

View Article and Find Full Text PDF